Protein breakthrough brings HIV vaccine closer to reality

Duke researchers have determined the structure of a key part of the HIV envelope protein gp41, potentially helping focus HIV vaccine development efforts. The research provides insight into the dramatic structural changes an HIV virus undergoes when it fuses to a host cell and may be an Achilles heel of vulnerability for HIV. Read More